Endovascular devices and methods

Information

  • Patent Grant
  • 11076882
  • Patent Number
    11,076,882
  • Date Filed
    Tuesday, October 30, 2018
    5 years ago
  • Date Issued
    Tuesday, August 3, 2021
    2 years ago
Abstract
Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing an intravascular device having a distal portion, inserting the device into the vascular lumen, positioning the distal portion in the vascular wall to at least partially surround the occlusion, and removing at least a portion of the surrounded occlusion from the lumen.
Description
TECHNICAL FIELD

The inventions described herein relate to devices and associated methods for the treatment of chronic total occlusions. More particularly, the inventions described herein relate to devices and methods for crossing chronic total occlusions and subsequently performing balloon angioplasty, stenting, atherectomy, or other endovascular methods for opening occluded blood vessels.


BACKGROUND

Due to age, high cholesterol and other contributing factors, a large percentage of the population has arterial atherosclerosis that totally occludes portions of the patient's vasculature and presents significant risks to patient health. For example, in the case of a total occlusion of a coronary artery, the result may be painful angina, loss of cardiac tissue or patient death. In another example, complete occlusion of the femoral and/or popliteal arteries in the leg may result in limb threatening ischemia and limb amputation.


Commonly known endovascular devices and techniques are either inefficient (time consuming procedure), have a high risk of perforating a vessel (poor safety) or fail to cross the occlusion (poor efficacy). Physicians currently have difficulty visualizing the native vessel lumen, can not accurately direct endovascular devices toward visualized lumen, or fail to advance devices through the lesion. Bypass surgery is often the preferred treatment for patients with chronic total occlusions, but less invasive techniques would be preferred.


SUMMARY

To address this and other unmet needs, the present invention provides, in exemplary non-limiting embodiments, devices and methods for the treatment of chronic total occlusions. The disclosed methods and devices are particularly beneficial in crossing coronary total occlusions but may also be useful in other vessels including peripheral arteries and veins. In exemplary embodiments, total occlusions are crossed using methods and devices intended to provide a physician the ability to place a device within the subintimal space, delaminate the connective tissues between layers within the lesion or vessel wall, or remove tissues from the chronic total occlusion or surrounding vessel.


In an aspect of the disclosure, a subintimal device may be used to guide conventional devices (for example guide wires, stents, lasers, ultrasonic energy, mechanical dissection, or atherectomy) within the vessel lumen. Additionally, a subintimal device may be used to delaminate vessel wall layers and also may be used to remove tissue from the occlusive lesion or surrounding vessel wall. In one example, the positioning of a subintimal device or the establishment of a delamination plane between intima and medial layers is achieved through the use of a mechanical device that has the ability to infuse a fluid (for example saline). Fluid infusion may serve to apply a hydraulic pressure to the tissues and aid in layer delamination and may also serve to protect the vessel wall from the tip of the subintimal device and reduce the chance of vessel perforation. The infusion of fluid may be controlled by pressure or by volume.


Subintimal device placement may be achieved with a subintimal device directing catheter. The catheter may orient a subintimal device so that it passes along the natural delamination plane between intima and media. The catheter may orient the subintimal device in various geometries with respect to the vessel. For example, the subintimal device may be directed substantially parallel with respect to the vessel lumen or in a helical pattern such that the subintimal device encircles the vessel lumen in a coaxial fashion. The subintimal device directing catheter may be an inflatable balloon catheter having proximal and distal ends with two wire lumens. One lumen may accept a conventional guide wire while the second lumen may accept the subintimal device. In an alternative embodiment, the wire directing catheter may be a guide catheter with distal geometry that steers the subintimal device with the appropriate orientation to enter the subintimal space.


In an additional disclosure, a subintimal device intended to mechanically delaminate tissue layers may use a device that is inserted into the subintimal space in a first collapsed configuration and is released or actuated into a second expanded configuration. The device may then be withdrawn or manipulated to propagate the area of delamination.


An additional aspect of the disclosure may allow the physician to remove tissues from the lesion or vessel wall. In one embodiment, a subintimal device is circumferentially collapsed around the total occlusion. Tissue removal is performed through simple device withdrawal or through a procedure that first cuts connective tissues (i.e. the intimal layer proximal and distal of the lesion) and then removes the targeted tissue. In another embodiment, a tissue removal device is passed through the lesion within the native vessel lumen. The targeted tissues may be mechanically engaged and removed through device withdrawal.





BRIEF DESCRIPTION OF THE DRAWINGS

It is to be understood that both the foregoing summary and the following detailed description are exemplary. Together with the following detailed description, the drawings illustrate exemplary embodiments and serve to explain certain principles. In the drawings,



FIG. 1 shows an illustration of a heart showing a coronary artery that contains a chronic total occlusion;



FIG. 2 is a schematic representation of a coronary artery showing the intimal, medial and adventitial layers;



FIG. 3 is a partial sectional view of a subintimal device directing balloon catheter embodiment with fluid infusion through the subintimal device lumen within the device directing catheter;



FIG. 4 is a partial sectional view of a subintimal device directing balloon catheter embodiment with fluid infusion through the subintimal device;



FIG. 5 is a partial sectional view of an additional subintimal device directing guiding catheter embodiment with fluid infusion through the subintimal device;



FIGS. 6A and B are partial sectional views of a expandable delamination catheter;



FIGS. 7 A-D are partial sectional views of a circumferential subintimal tissue removal device;



FIGS. 8A-C are an example of subintimal device construction; and



FIGS. 9A and B are partial sectional views of an intraluminal rotational engagement tissue removal device.





DETAILED DESCRIPTION OF EXEMPLARY EMBODIMENTS

The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.


Referring to FIG. 1, a diseased heart 100 includes a chronic total occlusion 101 of a coronary artery 102. FIG. 2 shows coronary artery 102 with intimal layer 200 (for sake of clarity, the multi layer intima is shown as a single homogenous layer). Concentrically outward of the intima is the medial layer 201 (which also is comprised of more than one layer but is shown as a single layer). The transition between the external most portion of the intima and the internal most portion of the media is referred to as the subintimal space. The outermost layer of the artery is the adventitia 202.


In an aspect of the disclosure, a subintimal device may be used to guide conventional devices (for example guide wires, stents, lasers, ultrasonic energy, mechanical dissection, or atherectomy) within the vessel lumen. Additionally, a subintimal device may be used to delaminate vessel wall layers and also may be used to remove tissue from the occlusive lesion or surrounding vessel wall. In one embodiment, FIG. 3 shows a subintimal device directing catheter is 300 with its distal balloon 301 that has been advanced over a conventional guide wire 302 and inflated proximal to chronic total occlusion 101. For the sake of clarity, FIG. 3 shows a subintimal device path that is substantially parallel to the vessel lumen, but other orientations (i.e. helical) may also be considered. Subintimal device lumen 303 is positioned adjacent to the intimal layer 200 and subintimal device 304 has been advanced as to perforate the subintimal layer. A fluid source (i.e. syringe) 305 is in fluid communication with subintimal device lumen 303 through infusion lumen 306. Fluid may flow from the fluid source 305 through the subintimal device lumen 303 under a controlled pressure or a controlled volume. The infused fluid may enter the subintimal space 307 directly from the subintimal device lumen 303 or from the volume 308 defined by the distal end of the balloon 301 and the proximal edge of the lesion 101. FIG. 4 shows an alternative fluid infusion path where fluid source 305 is in fluid communication with a lumen within the subintimal device 304. FIG. 5 shows an alternative subintimal device directing guide catheter 500 where the distal end 501 has a predefined shape or the distal end has an actuating element that allows manipulation by the physician intra-operatively.


Another aspect of the disclosure may place a subintimal device within the subintimal space in a first collapsed configuration and releases or actuates the subintimal device to a second expanded configuration. The device may then be withdrawn or manipulated to propagate the subintimal dissection. In one embodiment, FIG. 6A shows a subintimal device with internal expandable element 600 that contains one or more expanding elements 601 contained in exterior sheath 602. FIG. 6B shows exterior sheath 602 in a retracted position allowing expanding elements 601 to elastically expand. The subintimal device is intended to be delivered through the aforementioned subintimal device delivery catheters.


An additional aspect of the disclosure may allow the physician to remove tissues from the lesion or vessel wall. FIG. 7A shows an embodiment where subintimal device directing balloon catheter is inflated within coronary artery 102 just proximal to chronic total occlusion 101. Subintimal device 304 is partially delivered around chronic total occlusion 102 coaxially outside the intimal layer 200 and coaxially inside medial layer 201 in a helical pattern. FIG. 7B shows a subintimal device capture catheter 702 positioned across the chronic total occlusion 101 over conventional guide wire 703 and within subintimal device 304. The distal 704 and proximal 705 ends of the subintimal device 304 have been captured and rotated as to reduce the subintimal device outside diameter and contain the lesion 101 and intima 200 within the coils' internal diameter. The device may be withdrawn through the use of a cutting element. For example, FIGS. 7C and D show the advancement of a cutting element 706 in two stages of advancement showing the cutting of intima 200 proximal of the occlusion 707 and intimal distal of the occlusion 708.


An additional aspect of the subintimal device is the construction of the device body. The flexibility and torquability of the device body can affect the physician's ability to achieve a subintimal path. The subintimal device body may be constructed in part or in to total of a single layer coil with geometric features along the coil length that allow adjacent coils to engage (for example mechanical engagement similar to the teeth of a gear). FIG. 8A shows coil 801 closely wound such that the multitude of teeth 802 along the coil edges are in contact such that the peaks of one coil falls within the valleys of the adjacent coil. A conventional coil reacts to an applied torsional load by diametrically expanding or contracting, thus forcing the wire surfaces within a turn of the coil to translate with respect to its neighboring turn. The construction of coil 801 resists the translation of wire surfaces within the coil thus resisting the diametric expansion or contraction (coil deformation). An increased resistance to coil deformation increases the torsional resistance of the device body while the coiled construction provides axial flexibility. An exemplary construction may include a metallic tube where the coil pattern 801 and teeth 802 are cut from the tube diameter using a laser beam. FIG. 8B shows subintimal device body 804 that is for example a continuous metallic tube with distal laser cut coil segment 801 and proximal solid tube 803. Tube materials include but are not limited to stainless steel and nickel titanium. Alternatively, the coil may be wound from a continuous wire. The wire has a cross section that for example has been mechanically deformed (stamped) to form the teeth and allow coil engagement. FIG. 8C shows an example of a laser cut tooth pattern from the circumference of a tube that has been shown in a flat configuration for purposes of illustration.


In another embodiment, a tissue removal device may be passed through the lesion within the native vessel lumen. FIG. 9A shows corkscrew device 900 with exterior sheath 902 engaging occlusion after delamination of the intimal layer 901 has been performed by the aforementioned methods and devices. FIG. 9B shows removal of the occlusion and a portion of the intimal layer through axial withdrawal of the corkscrew device.


From the foregoing, it will be apparent to those skilled in the art that the present invention provides, in exemplary non-limiting embodiments, devices and methods for the treatment of chronic total occlusions. Further, those skilled in the art will recognize that the present invention may be manifested in a variety of forms other than the specific embodiments described and contemplated herein. Accordingly, departures in form and detail may be made without departing from the scope and spirit of the present invention as described in the appended claims.

Claims
  • 1. A method of treating an occlusion in a vascular lumen defined by a vessel wall, the occlusion separating a portion of the vascular lumen proximal of the occlusion from a portion of the vascular lumen distal of the occlusion, comprising: inserting a guidewire into the vascular lumen and advancing a distal end of the guidewire to a position adjacent the occlusion;advancing a catheter over the guidewire into the vascular lumen to the position adjacent the occlusion, the catheter including a balloon proximate a distal end of the catheter, a guidewire lumen having the guidewire slidably disposed therein, and a device lumen extending to a distal opening;inflating the balloon to an inflated configuration against an intima of the vessel wall at the position adjacent the occlusion;advancing a distal portion of a subintimal device disposed within the device lumen out of the distal opening and through the intima into a subintimal space within the vessel wall such that a distal end of the subintimal device remains within the subintimal space upon concluding the advancement of the subintimal device; andwithdrawing the subintimal device from the subintimal space such that the subintimal space is only in fluid communication with the portion of the vascular lumen disposed proximal of the occlusion.
  • 2. The method of claim 1, further comprising: delaminating tissue layers of the vessel wall adjacent the occlusion.
  • 3. The method of claim 2, wherein delaminating tissue layers of the vessel wall includes infusing a fluid into the subintimal space.
  • 4. The method of claim 3, wherein the fluid is infused directly into the subintimal space from the device lumen.
  • 5. The method of claim 3, wherein the fluid is infused into the subintimal space through the subintimal device.
  • 6. The method of claim 2, wherein delaminating tissue layers of the vessel wall includes expanding the distal portion of the subintimal device from a collapsed configuration to an expanded configuration within the subintimal space.
  • 7. The method of claim 2, wherein delaminating tissue layers of the vessel wall includes manipulating the distal portion of the subintimal device within the subintimal space to delaminate tissue layers in the vessel wall.
  • 8. The method of claim 1, wherein the distal portion of the subintimal device is advanced along an exterior of the balloon.
  • 9. The method of claim 1, wherein the distal opening is positioned on an exterior of the balloon.
  • 10. The method of claim 9, wherein inflating the balloon positions the distal opening of the device lumen against the intima of the vessel wall.
  • 11. The method of claim 1, wherein the distal opening is located distal of a proximal end of the balloon.
  • 12. A method of treating an occlusion in a vascular lumen defined by a vessel wall, the occlusion separating a portion of the vascular lumen proximal of the occlusion from a portion of the vascular lumen distal of the occlusion, comprising: advancing a catheter into the vascular lumen to a position proximal of the occlusion, the catheter including a balloon proximate a distal end of the catheter and a device lumen extending to a distal opening located proximal of a distal end of the balloon;inflating the balloon to an inflated configuration against an intima of the vessel wall at the position adjacent the occlusion;advancing a distal portion of a subintimal device disposed within the device lumen out of the distal opening and through the intima into a subintimal space within the vessel wall while the balloon is inflated such that a distal end of the subintimal device remains in the subintimal space upon concluding the advancement of the subintimal device; andwithdrawing the subintimal device from the subintimal space such that the subintimal space is only in fluid communication with the portion of the vascular lumen disposed proximal of the occlusion.
  • 13. The method of claim 12, wherein the distal portion of the subintimal device is advanced along an exterior of the balloon.
  • 14. The method of claim 12, wherein the distal opening is positioned on an exterior of the balloon.
  • 15. The method of claim 14, wherein inflating the balloon positions the distal opening of the device lumen against the intima of the vessel wall.
  • 16. The method of claim 12, wherein the catheter is advanced into the vascular lumen along a guidewire slidably positioned in a guidewire lumen extending through the balloon.
  • 17. The method of claim 12, wherein the distal opening is located distal of a proximal end of the balloon.
  • 18. A method of treating an occlusion in a vascular lumen defined by a vessel wall, the occlusion separating a portion of the vascular lumen proximal of the occlusion from a portion of the vascular lumen distal of the occlusion, comprising: inserting a guidewire into the vascular lumen and advancing a distal end of the guidewire to a position adjacent the occlusion;advancing a catheter over the guidewire into the vascular lumen to the position adjacent the occlusion, the catheter including a balloon proximate a distal end of the catheter, a guidewire lumen extending through the balloon and having the guidewire slidably disposed therein, and a device lumen extending along an exterior of the balloon;inflating the balloon to an inflated configuration at the position adjacent the occlusion to position a distal portion of the device lumen against an intima of the vessel wall;advancing a distal portion of a subintimal device disposed within the device lumen through the intima into a subintimal space within the vessel wall such that a distal end of the subintimal device remains within the subintimal space upon concluding the advancement of the subintimal device;delaminating tissue layers of the vessel wall adjacent the occlusion; andwithdrawing the subintimal device from the subintimal space such that the subintimal space is only in fluid communication with the portion of the vascular lumen disposed proximal of the occlusion.
  • 19. The method of claim 18, wherein delaminating tissue layers of the vessel wall includes expanding the distal portion of the subintimal device from a collapsed configuration to an expanded configuration within the subintimal space.
  • 20. The method of claim 18, wherein delaminating tissue layers of the vessel wall includes manipulating the distal portion of the subintimal device within the subintimal space to delaminate tissue layers in the vessel wall.
CROSS REFERENCE TO RELATED APPLICATIONS

The present application is a continuation application of U.S. patent application Ser. No. 14/965,475, filed Dec. 10, 2015, which is a continuation of U.S. patent application Ser. No. 14/152,379, filed Jan. 10, 2014, now U.S. Pat. No. 9,237,897, which is a continuation of U.S. patent application Ser. No. 13/214,141, filed Aug. 19, 2011, now U.S. Pat. No. 8,636,712, which is a continuation of U.S. patent application Ser. No. 11/518,431, filed Sep. 11, 2006, now U.S. Pat. No. 8,025,655, which claims the benefit of U.S. Provisional Application No. 60/717,726, filed Sep. 15, 2005, and U.S. Provisional Application No. 60/716,287, filed Sep. 12, 2005. The entire disclosure of each of the above-referenced applications are incorporated by reference herein.

US Referenced Citations (255)
Number Name Date Kind
4020829 Willson et al. May 1977 A
4233983 Rocco Nov 1980 A
4569347 Frisbie Feb 1986 A
4581017 Sahota Apr 1986 A
4621636 Fogarty Nov 1986 A
4747821 Kensey et al. May 1988 A
4762130 Fogarty et al. Aug 1988 A
4774949 Fogarty et al. Oct 1988 A
4819634 Shiber et al. Apr 1989 A
4878495 Grayzel Nov 1989 A
4976689 Buchbinder et al. Dec 1990 A
4979939 Shiber et al. Dec 1990 A
4990134 Auth Feb 1991 A
5071406 Jang et al. Dec 1991 A
5127917 Niederhauser et al. Jul 1992 A
5193546 Shaknovich Mar 1993 A
5201753 Lampropoulos et al. Apr 1993 A
5263493 Avitall Nov 1993 A
5275310 Mielnik et al. Jan 1994 A
5275610 Eberbach Jan 1994 A
5324263 Kraus et al. Jun 1994 A
5356418 Shturman Oct 1994 A
5372587 Hammerslag et al. Dec 1994 A
5383856 Bersin Jan 1995 A
5385152 Abele et al. Jan 1995 A
5409453 Lundquist et al. Apr 1995 A
5415637 Khosravi et al. May 1995 A
5464395 Faxon et al. Nov 1995 A
5501667 Verduin Mar 1996 A
5505702 Arney Apr 1996 A
5534007 St. Germain et al. Jul 1996 A
5565883 Shimizu Oct 1996 A
5571122 Kelly et al. Nov 1996 A
5571169 Plaia et al. Nov 1996 A
5603720 Kieturakis Feb 1997 A
5643298 Nordgren et al. Jul 1997 A
5645529 Fagan et al. Jul 1997 A
5655546 Halpern Aug 1997 A
5655548 Nelson et al. Aug 1997 A
5695506 Pike et al. Dec 1997 A
5728133 Kontos et al. Mar 1998 A
5741270 Hansen et al. Apr 1998 A
5741429 Donadio et al. Apr 1998 A
5779721 Nash et al. Jul 1998 A
5807241 Heimberger et al. Sep 1998 A
5824071 Nelson et al. Oct 1998 A
5830222 Makower Nov 1998 A
5830224 Cohn et al. Nov 1998 A
5843050 Jones et al. Dec 1998 A
5843102 Kalmann et al. Dec 1998 A
5882329 Patterson et al. Mar 1999 A
5910133 Gould et al. Jun 1999 A
5916194 Jacobsen et al. Jun 1999 A
5935108 Katoh et al. Aug 1999 A
5936108 Lin et al. Aug 1999 A
5944686 Patterson et al. Aug 1999 A
5954713 Newman et al. Sep 1999 A
5957900 Ouchi et al. Sep 1999 A
5968064 Selmon et al. Oct 1999 A
5989276 Houser et al. Nov 1999 A
6010449 Selmon et al. Jan 2000 A
6013055 Bampos et al. Jan 2000 A
6015405 Schwartz et al. Jan 2000 A
6022343 Johnson et al. Feb 2000 A
6036707 Spaulding et al. Mar 2000 A
6036717 Mers et al. Mar 2000 A
6059750 Fogarty et al. May 2000 A
6068638 Makower May 2000 A
6071281 Burnside et al. Jun 2000 A
6071292 Makower et al. Jun 2000 A
6081738 Hinohara et al. Jun 2000 A
6099542 Cohn et al. Aug 2000 A
6117064 Apple et al. Sep 2000 A
6120516 Selmon et al. Sep 2000 A
6126649 VanTassel et al. Oct 2000 A
6155264 Ressemann et al. Dec 2000 A
6157852 Selmon et al. Dec 2000 A
6159225 Makower Dec 2000 A
6183432 Milo Feb 2001 B1
6186972 Nelson et al. Feb 2001 B1
6190353 Makower et al. Feb 2001 B1
6193546 Sadler Feb 2001 B1
6203559 Davis et al. Mar 2001 B1
6217527 Selmon et al. Apr 2001 B1
6217549 Selmon et al. Apr 2001 B1
6221049 Selmon et al. Apr 2001 B1
6231546 Milo et al. May 2001 B1
6231587 Makower May 2001 B1
6235000 Milo et al. May 2001 B1
6241667 Vetter et al. Jun 2001 B1
6246914 de la Rama et al. Jun 2001 B1
6254588 Jones et al. Jul 2001 B1
6258052 Milo Jul 2001 B1
6266550 Selmon et al. Jul 2001 B1
6277133 Kanesaka Aug 2001 B1
6283940 Mulholland Sep 2001 B1
6283951 Flaherty et al. Sep 2001 B1
6283983 Makower et al. Sep 2001 B1
6287317 Makower et al. Sep 2001 B1
6302875 Makower et al. Oct 2001 B1
6330684 Yamanaka et al. Dec 2001 B1
6337142 Harder et al. Jan 2002 B2
6358244 Newman et al. Mar 2002 B1
6375615 Flaherty et al. Apr 2002 B1
6379319 Garibotto et al. Apr 2002 B1
6387119 Wolf et al. May 2002 B2
6398798 Selmon et al. Jun 2002 B2
6416523 Lafontaine Jul 2002 B1
6428552 Sparks Aug 2002 B1
6432127 Kim et al. Aug 2002 B1
6447518 Krause et al. Sep 2002 B1
6447539 Nelson et al. Sep 2002 B1
6475226 Belef Nov 2002 B1
6485458 Takahashi Nov 2002 B1
6491660 Guo et al. Dec 2002 B2
6491707 Makower et al. Dec 2002 B2
6506178 Schubart Jan 2003 B1
6506189 Rittman, III et al. Jan 2003 B1
6508824 Flaherty et al. Jan 2003 B1
6508825 Selmon et al. Jan 2003 B1
6511456 Salinas et al. Jan 2003 B1
6511458 Milo et al. Jan 2003 B2
6514217 Selmon et al. Feb 2003 B1
6544230 Flaherty et al. Apr 2003 B1
6561998 Roth et al. May 2003 B1
6565583 Deaton May 2003 B1
6569143 Alchas et al. May 2003 B2
6569145 Shmulewitz et al. May 2003 B1
6569150 Teague et al. May 2003 B2
6579311 Makower Jun 2003 B1
6589164 Flaherty Jul 2003 B1
6589208 Ewers et al. Jul 2003 B2
6599304 Selmon et al. Jul 2003 B1
6602241 Makower et al. Aug 2003 B2
6613081 Kim et al. Sep 2003 B2
6616675 Evard et al. Sep 2003 B1
6623448 Slater Sep 2003 B2
6638247 Selmon et al. Oct 2003 B1
6638293 Makower et al. Oct 2003 B1
6652544 Houser et al. Nov 2003 B2
6655386 Makower et al. Dec 2003 B1
6656195 Peters et al. Dec 2003 B2
6660024 Flaherty et al. Dec 2003 B1
6663577 Jen et al. Dec 2003 B2
6669709 Cohn et al. Dec 2003 B1
6679861 Yozu et al. Jan 2004 B2
6685648 Flaherty et al. Feb 2004 B2
6685716 Flaherty et al. Feb 2004 B1
6694983 Wolf et al. Feb 2004 B2
6709444 Makower Mar 2004 B1
6719125 Hollander Apr 2004 B1
6719725 Milo et al. Apr 2004 B2
6726677 Flaherty et al. Apr 2004 B1
6746426 Flaherty et al. Jun 2004 B1
6746462 Selmon et al. Jun 2004 B1
6746464 Makower Jun 2004 B1
6786884 DeCant, Jr. et al. Sep 2004 B1
6800085 Selmon et al. Oct 2004 B2
6817973 Merril et al. Nov 2004 B2
6824550 Noriega et al. Nov 2004 B1
6830577 Nash et al. Dec 2004 B2
6837686 Di Paola Jan 2005 B2
6860892 Tanaka Mar 2005 B1
6863684 Kim et al. Mar 2005 B2
6866676 Kieturakis et al. Mar 2005 B2
6884225 Kato et al. Apr 2005 B2
6905505 Nash et al. Jun 2005 B2
6929009 Makower et al. Aug 2005 B2
6936056 Nash et al. Aug 2005 B2
6942641 Seddon Sep 2005 B2
6949125 Robertson Sep 2005 B2
6991617 Hektner et al. Jan 2006 B2
7004173 Sparks et al. Feb 2006 B2
7056325 Makower et al. Jun 2006 B1
7059330 Makower et al. Jun 2006 B1
7083586 Simmons et al. Aug 2006 B2
7094230 Flaherty et al. Aug 2006 B2
7105031 Letort Sep 2006 B2
7134438 Makower et al. Nov 2006 B2
7137990 Hebert et al. Nov 2006 B2
7159592 Makower et al. Jan 2007 B1
7179270 Makower Feb 2007 B2
7191015 Lamson et al. Mar 2007 B2
7229421 Jen et al. Jun 2007 B2
7316655 Garibotto et al. Jan 2008 B2
7377910 Katoh et al. May 2008 B2
7407506 Makower Aug 2008 B2
7465286 Patterson et al. Dec 2008 B2
7485107 DiFiore et al. Feb 2009 B2
7517352 Evans et al. Apr 2009 B2
7729738 Flaherty et al. Jun 2010 B2
7749193 Shalev Jul 2010 B2
7762985 Kabrick et al. Jul 2010 B2
7763012 Petrick et al. Jul 2010 B2
7803169 Shamay Sep 2010 B2
7878986 Jen et al. Feb 2011 B2
7918870 Kugler et al. Apr 2011 B2
7938819 Kugler et al. May 2011 B2
8025655 Kugler et al. Sep 2011 B2
8083727 Kugler et al. Dec 2011 B2
8172863 Robinson et al. May 2012 B2
8241325 Modesitt Aug 2012 B2
8257382 Rottenberg et al. Sep 2012 B2
8257383 Rottenberg et al. Sep 2012 B2
8308682 Kramer et al. Nov 2012 B2
8323261 Kugler et al. Dec 2012 B2
8337425 Olson et al. Dec 2012 B2
20010000041 Selmon et al. Mar 2001 A1
20010056273 C. Dec 2001 A1
20020029052 Evans et al. Mar 2002 A1
20020052637 Houser et al. May 2002 A1
20020103459 Sparks et al. Aug 2002 A1
20030028200 Berg et al. Feb 2003 A1
20030040737 Merril et al. Feb 2003 A1
20030109809 Jen et al. Jun 2003 A1
20030120195 Milo et al. Jun 2003 A1
20030167068 Amplatz Sep 2003 A1
20030236542 Makower Dec 2003 A1
20040015193 Lamson et al. Jan 2004 A1
20040059280 Makower et al. Mar 2004 A1
20040102719 Keith et al. May 2004 A1
20040133225 Makower Jul 2004 A1
20040158143 Flaherty et al. Aug 2004 A1
20040167554 Simpson et al. Aug 2004 A1
20040230156 Schreck et al. Nov 2004 A1
20040249277 Kato et al. Dec 2004 A1
20040249338 DeCant, Jr. et al. Dec 2004 A1
20050038467 Hebert et al. Feb 2005 A1
20050049574 Petrick et al. Mar 2005 A1
20050171478 Selmon et al. Aug 2005 A1
20050177105 Shalev Aug 2005 A1
20050216044 Hong Sep 2005 A1
20050261663 Patterson et al. Nov 2005 A1
20060094930 Sparks et al. May 2006 A1
20060135984 Kramer et al. Jun 2006 A1
20060271078 Modesitt Nov 2006 A1
20070083220 Shamay Apr 2007 A1
20070088230 Terashi et al. Apr 2007 A1
20070093779 Kugler et al. Apr 2007 A1
20070093780 Kugler et al. Apr 2007 A1
20070093781 Kugler et al. Apr 2007 A1
20070093782 Kugler et al. Apr 2007 A1
20070093783 Kugler et al. Apr 2007 A1
20070265596 Jen et al. Nov 2007 A1
20080103443 Kabrick et al. May 2008 A1
20080228171 Kugler et al. Sep 2008 A1
20080243065 Rottenberg et al. Oct 2008 A1
20080243067 Rottenberg et al. Oct 2008 A1
20090088685 Kugler et al. Apr 2009 A1
20090124899 Jacobs et al. May 2009 A1
20090209910 Kugler et al. Aug 2009 A1
20090270890 Robinson et al. Oct 2009 A1
20100063534 Kugler et al. Mar 2010 A1
20100069945 Olson et al. Mar 2010 A1
20120071854 Kugler et al. Mar 2012 A1
Foreign Referenced Citations (8)
Number Date Country
0178822 Oct 2001 WO
2007033052 Mar 2007 WO
2008063621 May 2008 WO
2009054943 Apr 2009 WO
2009100129 Aug 2009 WO
2009134346 Nov 2009 WO
2010019241 Feb 2010 WO
2010044816 Apr 2010 WO
Non-Patent Literature Citations (3)
Entry
Bolia, “Subintimal Angioplasty: Which Cases to Choose, How to Avoid Pitfall and Technical Tips,” Combined Session: Vascular Surgery and Interventional Radiology, p. III 8.1-8.3.
Colombo et al., “Treating Chronic Total Occlusions Using Subintimal Tracking and Reentry: The STAR Technique,” Catheterization and Cardiovascular Interventions, 2005, vol. 64, pp. 407-411.
International Search Report in PCT/US06/35244 dated Mar. 24, 2008.
Related Publications (1)
Number Date Country
20190059927 A1 Feb 2019 US
Provisional Applications (2)
Number Date Country
60717726 Sep 2005 US
60716287 Sep 2005 US
Continuations (4)
Number Date Country
Parent 14965475 Dec 2015 US
Child 16174518 US
Parent 14152379 Jan 2014 US
Child 14965475 US
Parent 13214141 Aug 2011 US
Child 14152379 US
Parent 11518431 Sep 2006 US
Child 13214141 US